Advertisement
Research Article Free access | 10.1172/JCI116160
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Gaschet, J. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Mahé, B. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Milpied, N. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Devilder, M. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Dréno, B. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Bignon, J. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Davodeau, F. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Hallet, M. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Bonneville, M. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 211, CHR Nantes, France.
Find articles by Vié, H. in: JCI | PubMed | Google Scholar
Published January 1, 1993 - More info
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after allogeneic bone marrow transplantation (BMT) are poorly understood. The exact role of various effector cell populations and "major" (particularly HLA-DP) or "minor" antigens as target molecules is not known. To investigate the nature of cells responsible for tissue injury, we cultured T cells from skin biopsy first with interleukin 2 (IL-2) alone and then in polyclonal activation conditions to avoid in vitro antigenic sensitization before specificity testing. We applied this method to two biopsies performed during aGVHD after semiallogeneic BMT and obtained cytotoxic T cells against four graft mismatches: CD8+ T cells against HLA-A2.2 and HLA-B27 and CD4+ T cells against HLA-DP101 and HLA-DP401. This demonstrates that T cells with documented specificity can be obtained from an aGVHD lesion without antigenic selection. Moreover, these data directly implicate DP as a potential target antigen for aGVHD.
Images.